Home 1.1

With nearly two decades experience as an in-house and external counsel in the pharmaceutical and medical device sectors, I bring solid expertise and understanding of the business across the entire product life cycle

Interim Legal & Compliance Support

Close collaboration with legal, compliance, quality, and business teams

Interim Legal & Compliance Support

Immediate availability for ongoing or urgent matters and clear guidance in complex regulatory and organizational situations.

Interim Legal & Compliance Support

Practical, business-oriented advice — not abstract legal theory

Biography

Samantha Regenthal is a specialist in life sciences laws and regulations, based in Switzerland. Before founding her own company in 2014, Samantha worked as an inhouse counsel at F.Hoffmann-La Roche headquarters in Basel, Switzerland and as Head Legal Services at the life sciences boutique consultancy SFL in Basel, Switzerland.

She is counselling clients on legal, regulatory and compliance matters associated with pharmaceutical and medtech product development and marketing and is frequently involved in governance and policymaking activities. In addition, she possesses recognised expertise in EU competition
law.

As of 2025, Samantha is also active in the field of international arbitration and mediation,with a focus on life sciences disputes.

Samantha is a Swedish national. Her working languages are English, German and Swedish.

academic qualifications

CAS in Arbitration, Universities of Neuchâtel and Lucerne, Swiss Arbitration Academy, Switzerland, 2025
LL.M., University of Constance, Germany, 2007
CAS in Competition Law / Antitrust, University of Constance, Germany, 2006
Master of Laws, Lund University, Sweden, 2006

Publications

New Publication 2025

Investment Treaty Arbitration and Access to Medicines

In: ASA Bulletin Volume 43, Issue 1 (2025) pp. 7-33

Read It Here

Potential Impact on life-sciences. Proposed EU data protection regulation: Potential Impact on life-sciences

In: European Pharmaceutical Contractor, Fall 2014

Company Compliance

In: European Pharmaceutical Contractor, Winter 2013

Anmerkung zu EuGH, Urteil vom 26.4.2007, C-348/04Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.
("Remark to the Judgement in Case C-348/04 Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.")

In: GPR Zeitschrift für Gemeinschaftsprivatrecht, Feb. 2008

Die Beurteilung einer marktbeherrschenden Stellung unter besonderer Berücksichtigung des "more economic approach
The assessment of a dominant position in the light of „the more economic approach"")

In: Wirtschaft und Wettbewerb; vol. 56, afl. 12, pag. 1230-1237 / 2006, with Prof. Franz Böni , 2006

The law of abuse - a more economic approach to article 82

Master thesis, Lund University, Sweden 2006

INTERIM LIFE-SCIENCES LEGAL SUPPORT

Interim Legal & Compliance Support

Interim Legal & Compliance Support

Interim Legal & Compliance Support

Biography

academic qualifications

Publications

Investment Treaty Arbitration and Access to Medicines​

Potential Impact on life-sciences. Proposed EU data protection regulation: Potential Impact on life-sciences

Company Compliance

Anmerkung zu EuGH, Urteil vom 26.4.2007, C-348/04Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.("Remark to the Judgement in Case C-348/04 Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.")​

Die Beurteilung einer marktbeherrschenden Stellung unter besonderer Berücksichtigung des "more economic approachThe assessment of a dominant position in the light of „the more economic approach"")

The law of abuse - a more economic approach to article 82

Investment Treaty Arbitration and Access to Medicines

Anmerkung zu EuGH, Urteil vom 26.4.2007, C-348/04Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.
("Remark to the Judgement in Case C-348/04 Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.")

Die Beurteilung einer marktbeherrschenden Stellung unter besonderer Berücksichtigung des "more economic approach
The assessment of a dominant position in the light of „the more economic approach"")